广发纳斯达克生物科技美元(001093)
动态评分： 5.90分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2022-06-30 | NVCR | NovoCure Ltd | 买入 | 55.18 | 0.38% |
| 2022-06-30 | ARGX | argenx SE ADR | 买入 | 50.03 | 0.35% |
| 2022-06-30 | BNTX | BioNTech SE ADR | 买入 | 49.55 | 0.34% |
| 2022-06-30 | JAZZ | 爵士制药 | 买入 | 38.02 | 0.26% |
| 2022-06-30 | ZGNX US | Zogenix Inc | 卖出 | 19.02 | 0.13% |
| 2022-06-30 | AUPH | Aurinia Pharmaceuticals Inc | 卖出 | 13.4 | 0.09% |
| 2022-06-30 | BEAM | Beam Therapeutics Inc | 卖出 | 8.1 | 0.06% |
| 2022-06-30 | IONS | Ionis Pharmaceuticals Inc | 卖出 | 8.09 | 0.06% |
| 2022-06-30 | HALO | 奥洛兹美医疗 | 卖出 | 8.4 | 0.06% |
| 2022-06-30 | BPMC | Blueprint Medicines Corp | 卖出 | 6.87 | 0.05% |
| 2022-06-30 | TWST | Twist Bioscience Corp | 卖出 | 7.52 | 0.05% |
| 2022-06-30 | CRSP | CRISPR Therapeutics AG | 卖出 | 7.26 | 0.05% |
| 2022-06-30 | KOD | Kodiak Sciences Inc | 卖出 | 7.05 | 0.05% |
| 2022-06-30 | BDSI US | BioDelivery Sciences International Inc | 卖出 | 5.43 | 0.04% |
| 2022-06-30 | RETA | Reata Pharmaceuticals Inc-A | 卖出 | 2.33 | 0.02% |
| 2022-06-30 | URGN | 乌龙制药 | 卖出 | 0.08 | 0% |
| 2022-06-30 | TXMD | TherapeuticsMD Inc | 卖出 | 0.62 | 0% |
| 2021-12-31 | AMGN | 安进 | 买入 | 443.58 | 4.41% |
| 2021-12-31 | AZN | 阿斯利康(US ADR) | 买入 | 394.78 | 3.92% |
| 2021-12-31 | MRNA | Moderna Inc | 买入 | 375.46 | 3.73% |
公告&资料
